InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases. Founded in 2020, Innoskel is backed by investors that include Vida Ventures, Jeito Capital, Turenne Capital, and Region Sud Investissement and is headquartered in Valbonne.
FOUNDED:
2020
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
